HomeP8A • SGX
add
Cordlife Group Ltd
Previous close
$0.18
Day range
$0.18 - $0.18
Year range
$0.12 - $0.47
Market cap
45.52M SGD
Avg Volume
66.40K
P/E ratio
-
Dividend yield
-
Primary exchange
SGX
Market news
Financials
Income Statement
Revenue
Net income
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.60M | -67.54% |
Operating expense | 8.59M | -6.80% |
Net income | -6.18M | -655.33% |
Net profit margin | -134.45 | -1,810.56% |
Earnings per share | — | — |
EBITDA | -6.84M | -615.37% |
Effective tax rate | 8.73% | — |
Balance Sheet
Total assets
Total liabilities
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.54M | -15.89% |
Total assets | 224.31M | -4.16% |
Total liabilities | 101.27M | 3.31% |
Total equity | 123.03M | — |
Shares outstanding | 256.31M | — |
Price to book | 0.36 | — |
Return on assets | -8.79% | — |
Return on capital | -15.66% | — |
Cash Flow
Net change in cash
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -6.18M | -655.33% |
Cash from operations | -2.95M | -192.71% |
Cash from investing | 2.90M | 258.76% |
Cash from financing | -549.50K | -19.59% |
Net change in cash | -498.00K | -153.06% |
Free cash flow | -4.65M | -1,473.26% |
About
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
In January 2018, Cordlife acquired HealthBaby Biotech Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. Wikipedia
CEO
Founded
May 2, 2001
Website
Employees
111
